CJC-1295 — Growth Hormone Signaling Research

CJC-1295 has been investigated as an analog of growth hormone-releasing hormone (GHRH). Published research on the long-acting compound examines growth hormone and IGF-1 responses. The exact molecular form matters when interpreting those findings.

At a glance

• Primary focus: GHRH signaling and downstream hormone responses.
• Variant confirmation is essential: published long-acting CJC-1295 findings should not be applied automatically to “no DAC” products.
• A measured hormone response does not prove better recovery, sleep, body composition, or longevity.

Evidence and intended use

Clinical evidence is limited, and FDA has identified safety concerns with CJC-1295. This listing does not establish a safe or effective anti-aging or performance treatment.

Common question

Is this CJC-1295 with DAC or without DAC?
The variant has not been supplied. Confirm the supplier specification before evaluating or selecting this product.

Product details

Confirm the exact formulation, strength, package size, and intended use against the supplier label. Refer to the manufacturer documentation for storage and handling information.